Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Child's Nervous System
Published in: Child's Nervous System 2/2007

01-02-2007 | Original Paper

Short echo time 1 H magnetic resonance spectroscopy of childhood brain tumours

Authors: A. C. Peet, S. Lateef, L. MacPherson, K. Natarajan, S. Sgouros, R. G. Grundy

Published in: Child's Nervous System | Issue 2/2007

Login to get access

Abstract

Aims

To explore short echo time (30 ms) 1 H magnetic resonance spectroscopy (MRS) in children with brain tumours and determine the contributions to the characterization of these tumours of the metabolites inositol/myoinositol and glutamate/glutamine, which are not visible at long echo times (135 or 270 ms).

Methods

Over a 12-month period 86 single-voxel MRS investigations were performed on 59 children with various brain tumours on a Siemens Symphony 1.5-T Magnetom using point-resolved spectroscopy and echo time of 30 ms.

Results

The procedure was well tolerated, and good-quality data were obtained. N-Acetyl aspartate (NAA)/Choline (Cho) and creatine (Cr)/Cho concentration ratios were significantly (p<0.001) lower in tumour (0.95 and 1.63, respectively) compared with non-involved brain (3.68 and 3.98, respectively) in all histological types. Inositol/Myoinositol (Inos)/Cho ratios were significantly (p<0.05) lower in untreated tumours (1.91) than in treated tumours (3.93) and in non-involved brain (3.32). Inos/Cho ratios were high in diffuse pontine gliomas and low in medulloblastomas and supratentorial primitive neuroectodermal tumours (p<0.01). Glutamate/Glutamine (Glut)/Cho ratios were high in grade 1 astrocytomas (6.4) and unbiopsied optic gliomas (9.84) but low in diffuse pontine gliomas (2.44). Lipids and macromolecules were present in most tumours but in low quantities in non-involved brain.

Conclusion

Good-quality short echo time MRS data can be collected routinely on children with brain tumours. Inos and Glut levels show greater variability between tumour types than NAA, Cho and Cr present at long echo times, providing improved tumour characterization. Inos/Cho levels differ between untreated and treated tumours and may be useful for treatment monitoring.
Literature
1.
Astrakas LG, Zurakowski D, Tzikka AA et al (2004) Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 10:8220–8228PubMedCrossRef
2.
Burtscher IM, Skagerberg G, Geijer B et al (2000) Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterised by stereotactic biopsy findings. Am J Neuroradiol 21:84–93PubMed
3.
Girard N, Wang ZJ, Erbetta A et al (1998) Prognostic value of proton MR spectroscopy of cerebral hemisphere tumours in children. Neuroradiology 40:121–125PubMedCrossRef
4.
Howe FA, Opstad KS (2003) 1 H MR spectroscopy of brain tumours and masses. NMR Biomed 16:123–131PubMedCrossRef
5.
Lindskog M, Kogner P, Ponthan F et al (2003) Non invasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1 H MRS). Br J Cancer 88:478–485PubMedCrossRef
6.
Muckherji SK (ed) (1998) Clinical applications of MR spectroscopy. Wiley-Liss, New York
7.
Opstad KS, Provencher SW, Bell BA et al (2003) Detection of elevated glutathione in meningiomas by quantitative in vivo 1 H MRS. Magn Reson Med 49:632–637PubMedCrossRef
8.
Peet A, Garala P, MacPherson L, Natarajan K, Sgouros S, Grundy R (2004) Mobile lipids detected by short echo time 1 H magnetic resonance spectroscopy correlate with malignancy in childhood brain tumours. Neuro-oncol 6:471
9.
Peet A, Garala P, MacPherson L, Natarajan K, Sgouros S, Grundy R (2004) Short echo time 1 H magnetic resonance spectroscopy of childhood brain tumours. Childs Nerv Syst 20(5):256
10.
Peet AC, Leach MO, Pinkerton CR, Price P, Williams SR, Grundy RG (2005) The development of functional imaging for the diagnosis, management and understanding of childhood brain tumours—an EPSRC workshop. Paediatr Blood Cancer 44:103–113CrossRef
11.
Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679PubMedCrossRef
12.
Pruel MC, Caramanos Z, Collins DL et al (1996) Accurate, noninvasive diagnosis of human brain tumours by using proton magnetic resonance spectroscopy. Nat Med 2:323–325CrossRef
13.
Pruel MC, Caramanos Z, Leblanc R et al (1998) Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumours. NMR Biomed 11:192–200CrossRef
14.
Thiesse P, Jaspan T, Couanet D et al (2001) Un Protocols d’imager des tumeurs cerebrales de l’enfant (A protocol for imaging paediatric brain tumours). J Radiol 82:177–191
15.
Tzika AA, Astrakas LG, Zarifi MK et al (2003) Multiparametric MR assessment of paediatric brain tumours. Neuroradiology 2002:1–10
16.
Tzika AA, Astrakas LG, Zarifi MK et al (2004) Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumours. Cancer 100:1246–1256PubMedCrossRef
17.
Tzika AA, Zarifi MK, Goumnerova L et al (2002) Neuroimaging in pediatric brain tumours: Gd-DTPA-enhanced hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. Am J Neuroradiol 23:322–333PubMed
18.
Vaidya SJ, Payne GS, Leach MO et al (2003) Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer. Eur J Cancer 39:728–735PubMedCrossRef
19.
Wilke M, Eidenschink A, Muller-Weihrich S, Auer DP (2001) MR diffusion imaging and 1 H spectroscopy in a child with medulloblastoma. A case report. Acta Radiol 42:39–42PubMed
20.
Wilkinson ID, Griffiths PD, Wales JK (2001) Proton magnetic resonance spectroscopy of brain lesions in children with neurofibromatosis type 1. Magn Reson Imag 19:1081–1089CrossRef
Metadata
Title
Short echo time 1 H magnetic resonance spectroscopy of childhood brain tumours
Authors
A. C. Peet
S. Lateef
L. MacPherson
K. Natarajan
S. Sgouros
R. G. Grundy
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Child's Nervous System / Issue 2/2007
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-006-0206-4

Other articles of this Issue 2/2007

Child's Nervous System 2/2007 Go to the issue

Commentary

CSF leak and pseudomeningocele formation after posterior fossa tumor resection in children: a retrospective analysis

Case Report

Giant prolactinomas in adolescence: an uncommon cause of blindness

Case Report

Trimyelia with divergent cord pathways and three foramina magni

Original Paper

Cerebellopontine angle lesions in children

Original Paper

Pediatric arteriovenous malformation: University of Toronto experience using stereotactic radiosurgery

Case Illustration

Flexible and floating choroid plexus cyst of the third ventricle: an ultrasonographic video documentation